Stephanie E. Barrett

Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention

Stephanie E. Barrett, Ryan S. Teller, Seth Forster et al. · Antimicrobial Agents and Chemotherapy · 2018 · 130 citations · Full text

In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection

Perry Tsai, Guoxin Wu, Caroline Baker et al. · Retrovirology · 2016 · 66 citations · Full text

Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial

Randolph P. Matthews, Munjal Patel, Stephanie E. Barrett et al. · Nature Medicine · 2021 · 65 citations

Islatravir Subdermal Implant, Treatment And Prevention, Human Retrovirus +8

Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates

Stephanie E. Barrett, Rob S. Burke, Marc Abrams et al. · Journal of Controlled Release · 2014 · 30 citations

Cell-based Drug Delivery, Nanomedicine, Engineering +7

A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection

Randolph P. Matthews, Xiaowei Zang, Stephanie E. Barrett et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2022 · 25 citations · Full text